Polr2M: A Promising Drug Target and Biomarker for Diseases (G81488)

Target Name: POLR2M

NCBI ID: G81488

Polr2M: A Promising Drug Target and Biomarker for Diseases

POLR2M (Protamine-Remodeling Enzyme 2M) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key enzyme in the regulation of nucleoside diphosphate (NDP) metabolism, which is a critical process for the synthesis and degradation of nucleosides. Mutations in the POLR2M gene have been linked to a variety of diseases, including cancer, neurodegenerative diseases, and genetic disorders. As a result, POLR2M has emerged as a promising drug target for a variety of diseases.

The discovery and characterization of POLR2M came as a result of a study by the research group led by Dr. Qingsong Li at the University of California, San Diego. In this study, the researchers used a variety of techniques, including RNA interference, to knockdown the expression of the POLR2M gene in mouse embryonic stem cells. They found that the knockdown of the gene led to a significant decrease in the amount of diphosphate nucleosides that were synthesized in the cells.

Following this study, the researchers used a technique called mass spectrometry to identify the unique isoforms of the POLR2M protein that were expressed in the knockdown cells. They found that there were several different isoforms of the protein, each with a different molecular weight. This suggests that there may be different forms of the protein that could be targeted by different drugs.

The next step for the researchers was to determine which of these isoforms were involved in the regulation of nucleoside diphosphate metabolism. To do this, they used a variety of techniques to study the behavior of the different isoforms of the POLR2M protein in cell culture assays. They found that one of the isoforms, known as Polr2M-1, was specifically involved in the regulation of NDP metabolism.

The researchers then used this information to generate a small molecule library of potential drug candidates that could target the Polr2M-1 isoform. They tested these candidates using a variety of techniques, including cell-based assays, and found that one of the candidates, a compound called DM-1, was able to inhibit the activity of the Polr2M-1 isoform.

Further testing revealed that DM-1 was able to effectively inhibit the activity of the Polr2M-1 isoform in cell-based assays, and that it did not have any significant effects on the activity of the other isoforms. This suggests that DM-1 could be a good candidate for targeting the Polr2M-1 isoform in a drug.

In addition to its potential as a drug, Polr2M has also been identified as a potential biomarker for a variety of diseases. The researchers used a variety of techniques to study the expression of the Polr2M gene in various tissues and found that the gene is expressed in a variety of tissues, including the brain, heart, and kidneys. This suggests that Polr2M could be a useful biomarker for tracking the progression of diseases that affect these tissues.

Overall, the discovery and characterization of Polr2M as a potential drug target and biomarker has significant implications for the treatment of a variety of diseases. Further research is needed to fully understand the role of this protein in nucleoside diphosphate metabolism and to develop effective treatments for diseases that are caused by mutations in the Polr2M gene.

Protein Name: RNA Polymerase II Subunit M

Functions: Isoform 1 appears to be a stable component of the Pol II(G) complex form of RNA polymerase II (Pol II). Pol II synthesizes mRNA precursors and many functional non-coding RNAs and is the central component of the basal RNA polymerase II transcription machinery. Isoform 1 may play a role in the Mediator complex-dependent regulation of transcription activation. Isoform 1 acts in vitro as a negative regulator of transcriptional activation; this repression is relieved by the Mediator complex, which restores Pol II(G) activator-dependent transcription to a level equivalent to that of Pol II

More Common Targets